IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 50.05% | -11.40% | -373.53% | 120.39% | -23.04% |
Total Depreciation and Amortization | 1.45% | -68.78% | 217.87% | -134.09% | 187.96% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -223.75% | 131.02% | 52.15% | -1,111.26% | 226.00% |
Change in Net Operating Assets | 192.83% | -80.57% | 18.11% | 53,250.00% | 99.72% |
Cash from Operations | 45.14% | 18.77% | -46.82% | 54.78% | 26.63% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -114.29% | -91.36% | 1,520.00% | -58.33% | -80.33% |
Cash from Investing | -114.29% | 133.33% | 112.00% | -110.04% | 441.30% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -2,033.33% | 10.58% | 82.22% | 44.39% | 30.47% |
Issuance of Common Stock | -- | -- | 130.65% | -61.04% | 15,648.39% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -20.33% | -59.00% | 225.21% | -65.39% | 356.75% |
Foreign Exchange rate Adjustments | 575.00% | 144.44% | -181.82% | 266.67% | 150.00% |
Miscellaneous Cash Flow Adjustments | 0.00% | -- | -- | -- | -- |
Net Change in Cash | 93.16% | -202.04% | 195.39% | 0.71% | 88.17% |